Kiora Pharmaceuticals Stock Performance

KPRX Stock  USD 0.71  0.09  14.52%   
On a scale of 0 to 100, Kiora Pharmaceuticals holds a performance score of 5. The company secures a Beta (Market Risk) of -1.5, which conveys a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Kiora Pharmaceuticals are expected to decrease by larger amounts. On the other hand, during market turmoil, Kiora Pharmaceuticals is expected to outperform it. Please check Kiora Pharmaceuticals' value at risk, as well as the relationship between the kurtosis and price action indicator , to make a quick decision on whether Kiora Pharmaceuticals' current price movements will revert.

Risk-Adjusted Performance

5 of 100

 
Low
 
High
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Kiora Pharmaceuticals are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile basic indicators, Kiora Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point. ...more
Last Split Factor
1:40
Dividend Date
2019-08-30
Last Split Date
2022-09-27
1
Whats Going On With Kiora Pharmaceuticals Stock
02/01/2024
2
Kiora Pharmaceuticals Stock Price Up 2.1 percent - Defense World
02/07/2024
3
Kiora Announces Publication of Phase 1 Study Demonstrating Safety, Tolerability and Anti-Inflammatory Activity of KIO-101 in the Treatment of Inflammation of th...
03/08/2024
4
Kiora Pharmaceuticals Reports 2023 Results Continues to Advance Pipeline of Treatments for Rare Retinal Diseases
03/25/2024
Begin Period Cash FlowM
  

Kiora Pharmaceuticals Relative Risk vs. Return Landscape

If you would invest  52.00  in Kiora Pharmaceuticals on December 29, 2023 and sell it today you would earn a total of  10.00  from holding Kiora Pharmaceuticals or generate 19.23% return on investment over 90 days. Kiora Pharmaceuticals is currently generating 0.5961% in daily expected returns and assumes 8.6443% risk (volatility on return distribution) over the 90 days horizon. In different words, 76% of stocks are less volatile than Kiora, and 89% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Kiora Pharmaceuticals is expected to generate 15.19 times more return on investment than the market. However, the company is 15.19 times more volatile than its market benchmark. It trades about 0.07 of its potential returns per unit of risk. The NYSE Composite is currently generating roughly 0.24 per unit of risk.

Kiora Pharmaceuticals Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Kiora Pharmaceuticals' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Kiora Pharmaceuticals, and traders can use it to determine the average amount a Kiora Pharmaceuticals' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.069

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsKPRX
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 8.64
  actual daily
76
76% of assets are less volatile

Expected Return

 0.6
  actual daily
11
89% of assets have higher returns

Risk-Adjusted Return

 0.07
  actual daily
5
95% of assets perform better
Based on monthly moving average Kiora Pharmaceuticals is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Kiora Pharmaceuticals by adding it to a well-diversified portfolio.

Kiora Pharmaceuticals Fundamentals Growth

Kiora Stock prices reflect investors' perceptions of the future prospects and financial health of Kiora Pharmaceuticals, and Kiora Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Kiora Stock performance.

About Kiora Pharmaceuticals Performance

To evaluate Kiora Pharmaceuticals Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Kiora Pharmaceuticals generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Kiora Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Kiora Pharmaceuticals market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Kiora's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2024
Return On Capital Employed(0.72)(0.68)
Return On Assets(0.91)(0.96)
Return On Equity(2.05)(1.95)

Things to note about Kiora Pharmaceuticals performance evaluation

Checking the ongoing alerts about Kiora Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Kiora Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Kiora Pharmaceuticals is way too risky over 90 days horizon
Kiora Pharmaceuticals has some characteristics of a very speculative penny stock
Kiora Pharmaceuticals appears to be risky and price may revert if volatility continues
Net Loss for the year was (12.51 M) with loss before overhead, payroll, taxes, and interest of (5.14 M).
Kiora Pharmaceuticals currently holds about 2.43 M in cash with (9.56 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.64, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Kiora Pharmaceuticals has a frail financial position based on the latest SEC disclosures
Latest headline from finance.yahoo.com: Kiora Pharmaceuticals Reports 2023 Results Continues to Advance Pipeline of Treatments for Rare Retinal Diseases
Evaluating Kiora Pharmaceuticals' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Kiora Pharmaceuticals' stock performance include:
  • Analyzing Kiora Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Kiora Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
  • Examining Kiora Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Kiora Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Kiora Pharmaceuticals' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Kiora Pharmaceuticals' stock. These opinions can provide insight into Kiora Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Kiora Pharmaceuticals' stock performance is not an exact science, and many factors can impact Kiora Pharmaceuticals' stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
When determining whether Kiora Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Kiora Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Kiora Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Kiora Pharmaceuticals Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kiora Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Kiora Stock please use our How to Invest in Kiora Pharmaceuticals guide.
You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Complementary Tools for Kiora Stock analysis

When running Kiora Pharmaceuticals' price analysis, check to measure Kiora Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kiora Pharmaceuticals is operating at the current time. Most of Kiora Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kiora Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kiora Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kiora Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Is Kiora Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kiora Pharmaceuticals. If investors know Kiora will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kiora Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
0.78
Revenue Per Share
0.002
Return On Assets
(0.38)
Return On Equity
(1.37)
The market value of Kiora Pharmaceuticals is measured differently than its book value, which is the value of Kiora that is recorded on the company's balance sheet. Investors also form their own opinion of Kiora Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Kiora Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kiora Pharmaceuticals' market value can be influenced by many factors that don't directly affect Kiora Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kiora Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Kiora Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kiora Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.